Literature DB >> 16951232

Selective profiling of proteins in lung cancer cells from fine-needle aspirates by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.

Joseph M Amann1, Pierre Chaurand, Adriana Gonzalez, James A Mobley, Pierre P Massion, David P Carbone, Richard M Caprioli.   

Abstract

PURPOSE: Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) has been used to analyze tumor sections and can determine tumor type, nodal involvement, and survival, and shows promise in predicting therapeutic response. Our purpose was to develop a method compatible with MALDI-TOF MS that allows selective analysis of cancer cells in mixed clinical samples such as fine-needle aspirates. EXPERIMENTAL
DESIGN: Lung cancer cell lines were cytocentrifuged onto metal-coated, transparent glass slides and used for optimization of fixation, staining, and RBC lysis protocols. Fine-needle aspirates from human tumors and mouse model tumors were used to provide fresh tissue samples for determining the feasibility of this method.
RESULTS: The MALDI-TOF MS compatible fixation and staining techniques provided high-resolution cellular morphology, which allowed identification and selective spotting of tumor cells. The RBC lysis step efficiently removed contaminating RBC yielding spectra nearly free from hemoglobin peaks. Protein profiles of fine-needle aspirates were found highly reproducible and similar to the profiles of the tissue from which they were obtained. Using this method, we were able to differentiate between xenograft tumors derived from two different human cell lines, A549 and H460.
CONCLUSION: This procedure results in the production of high-quality, cancer cell-specific protein profiles. This highly reproducible technique could be applied to many other types of mixed clinical samples and has the potential to be very useful in the clinical diagnosis, classification, and, potentially, the individualized treatment of cancer patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16951232     DOI: 10.1158/1078-0432.CCR-06-0264

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  11 in total

Review 1.  Mass spectrometry-based proteomic profiling of lung cancer.

Authors:  Sebahat Ocak; Pierre Chaurand; Pierre P Massion
Journal:  Proc Am Thorac Soc       Date:  2009-04-15

2.  Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS.

Authors:  Melinda E Sanders; Eduardo C Dias; Baogang J Xu; James A Mobley; Dean Billheimer; Heinrich Roder; Julia Grigorieva; Mitchell Dowsett; Carlos L Arteaga; Richard M Caprioli
Journal:  J Proteome Res       Date:  2008-04-04       Impact factor: 4.466

3.  Whole-cell MALDI-TOF mass spectrometry is an accurate and rapid method to analyze different modes of macrophage activation.

Authors:  Richard Ouedraogo; Aurélie Daumas; Christian Capo; Jean-Louis Mege; Julien Textoris
Journal:  J Vis Exp       Date:  2013-12-26       Impact factor: 1.355

4.  In situ mass spectrometry of autoimmune liver diseases.

Authors:  Christopher L Bowlus; Erin H Seeley; Joanna Roder; Julia Grigorieva; Heinrich Roder; Richard M Caprioli; Meric Gershwin
Journal:  Cell Mol Immunol       Date:  2011-01-24       Impact factor: 11.530

5.  Whole Cell MALDI Fingerprinting Is a Robust Tool for Differential Profiling of Two-Component Mammalian Cell Mixtures.

Authors:  Valentina Z Petukhova; Alexandria N Young; Jian Wang; Mingxun Wang; Andras Ladanyi; Rajul Kothari; Joanna E Burdette; Laura M Sanchez
Journal:  J Am Soc Mass Spectrom       Date:  2018-10-23       Impact factor: 3.109

Review 6.  Individualizing chemotherapy for non-small cell lung cancer (NSCLC) in the adjuvant and advanced setting: current status and future directions.

Authors:  George R Simon
Journal:  Curr Treat Options Oncol       Date:  2009-03-06

7.  Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation.

Authors:  Joshua A Bauer; A Bapsi Chakravarthy; Jennifer M Rosenbluth; Deming Mi; Erin H Seeley; Nara De Matos Granja-Ingram; Maria G Olivares; Mark C Kelley; Ingrid A Mayer; Ingrid M Meszoely; Julie A Means-Powell; Kimberly N Johnson; Chiaojung Jillian Tsai; Gregory D Ayers; Melinda E Sanders; Robert J Schneider; Silvia C Formenti; Richard M Caprioli; Jennifer A Pietenpol
Journal:  Clin Cancer Res       Date:  2010-01-12       Impact factor: 12.531

8.  Molecular imaging of proteins in tissues by mass spectrometry.

Authors:  Erin H Seeley; Richard M Caprioli
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-05       Impact factor: 11.205

9.  Distinguishing Non-Small Cell Lung Cancer Subtypes in Fine Needle Aspiration Biopsies by Desorption Electrospray Ionization Mass Spectrometry Imaging.

Authors:  Alena V Bensussan; John Lin; Chunxiao Guo; Ruth Katz; Savitri Krishnamurthy; Erik Cressman; Livia S Eberlin
Journal:  Clin Chem       Date:  2020-11-01       Impact factor: 8.327

10.  Reduced Hemoglobin Signal and Improved Detection of Endogenous Proteins in Blood-Rich Tissues for MALDI Mass Spectrometry Imaging.

Authors:  Monica Lin; Livia S Eberlin; Erin H Seeley
Journal:  J Am Soc Mass Spectrom       Date:  2022-01-21       Impact factor: 3.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.